QLS-1410

N/A

Report date: 2026/05/23 20:00:57
NME

Base Information

Drug NameQLS-1410
Drug Alias NameQLS1410QLS-1410
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 11B2 inhibitors
TargetsCytochrome P450 11B2
Therapy Area/IndicationsHyperaldosteronismHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesQilu Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsHyperaldosteronismHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A